secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZIMMER BIOMET HOLDINGS, INC. (ZBH)
CIK:        0001136869
Form:       8-K
Filed at:   2025-01-29T23:59:59+00:00
Accession:  0001193125-25-014881
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zimmer Biomet to acquire Paragon 28 for $13.00 per share cash plus up to $1.00 CVR
--------------------------------------------------------------------------------

- Deal consideration: $13.00 per share cash plus Contingent Value Right (CVR) with max $1.00 payable if Paragon 28 net revenue exceeds $361M in 2026.
- Paragon 28 CEO Albert DaCosta enters voting agreement to support deal, will become Global President, Foot and Ankle post-close.
- Termination fee of $40M payable by Paragon 28 under certain circumstances, including if it accepts a superior proposal.
- Closing requires stockholder approval, HSR and foreign regulatory clearances; no financing condition.
- Deal expected to close by November 28, 2025 (with possible extension to January 28, 2026).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1136869/000119312525014881/0001193125-25-014881-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1136869/000119312525014881/d925673d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-014881

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer